Table: Fuso Pharmaceutical -2024/25 parent results

Fuso Pharmaceutical Industries

09/05/2025 05:40

May 9 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           60.56           55.41          61.50        30.60    
               (+9.3 pct)      (+8.6 pct)     (+1.5 pct)    (+2.9 pct) 
  Operating        4.13            1.96           3.40         1.60    
              (+110.3 pct)     (-11.0 pct)    (-17.7 pct)  (-34.3 pct) 
  Recurring        3.78            1.87           3.30         1.60    
              (+102.4 pct)     (-15.7 pct)    (-12.7 pct)  (-25.4 pct) 
  Net              2.78            1.38           2.30         1.10    
              (+101.8 pct)     (-14.2 pct)    (-17.3 pct)  (-28.4 pct) 
  EPS          325.44 yen      159.98 yen     269.24 yen    128.77 yen 
  Ann Div       82.00 yen       70.00 yen      90.00 yen               
  -Q2 Div       40.00 yen       35.00 yen      45.00 yen               
  -Q4 Div       42.00 yen       35.00 yen      45.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T